Flyer

Acta Rheumatologica

  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
20+ Million Readerbase
Indexed In
  • OCLC- WorldCat
  • Publons
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Opinion - (2022) Volume 9, Issue 4

Significance of Monocytes & Macrophages in Spondyloarthritis

Ramel Jonsson*
 
National University Hospital of Iceland, Reykjavik, Iceland
 
*Correspondence: Ramel Jonsson, National University Hospital of Iceland, Reykjavik, Iceland, Email:

Received: 03-Aug-2022, Manuscript No. ipar-22-12502; Editor assigned: 05-Aug-2022, Pre QC No. ipar-22-12502 (PQ); Reviewed: 23-Aug-2022, QC No. ipar-22-12502; Revised: 24-Aug-2022, Manuscript No. ipar-22-12502 (Q); Published: 31-Aug-2022, DOI: 10.36648/ipar.22.9.4.11

Opinion

Spondyloarthritis (SpA) is a collection of chronic inflammatory illnesses that mostly affect the spine and joints, with the sacroiliac joint being the most commonly implicated [1]. These diseases, which affect about 1% of the global population, cause serious ailments, suffering, disability, resulting in significant health and economical concerns [2]. In contrast to other rheumatic diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), the prevalence of spondylarthritis is equivalent in males and females, and the disease's beginning (third-fourth decade) occurs sooner than in other rheumatic joint diseases. The innate immune system cells are the initial line of defence against infections. Mucosal-associated invariant T (MAIT) cells, invariant natural killer T (iNKT) cells, gamma delta T cells (T cells), innate lymphoid cells (ILCs), neutrophils, mast cells, eosinophils, and monocytes and macrophages are among these cell types [3]. Monocytes and macrophages play an important role in the activation of the innate immune system, releasing inflammatory cytokines such as TNF, IL-6, IL-1, and chemokines after pathogen detection, which activate and attract other immune cells to the inflammation sites [4].

In the pathophysiology of SpA, a genetic relationship has been demonstrated. The strongest link was discovered in the HLA-B27 gene, which encodes the human leukocyte antigen (HLA) class I molecule 27 (HLA-B27), a key risk factor for the development of SpA, particularly AS and USpA [5]. Human leukocyte antigens (HLA), also known as Major Histocompatibility Complex (MHC), are in charge of presenting intracellular and extracellular peptides to immune system cells for activation. HLA-B27 is an MHC class I molecule that presents intracellular peptides to CD8+ T lymphocytes [6]. A number of epigenetic imbalances have also been linked to SpA development. Methylation is an important epigenetic mechanism involved in several illnesses, including SpA. Aberrant methylation is caused by an increase in the addition of methyl groups in specific gene regions. As a result, hypermethylation of promoter regions reduces gene expression, frequently exacerbating pathogenic symptoms [7]. In AS patients, GWAS studies revealed differentially methylation sites in the HLA-DQB1 gene. MicroRNAs (miRNAs) are also key epigenetic factors, and several studies have found that various miRNAs are dysregulated in SpA patients. One of the most significant studies discovered a pattern of 13 miRNAs unregulated in monocytes and 11 miRNAs deregulated in CD4+ T cells in patients with axSpA compared to controls, both of which are implicated in the pathogenesis of SpA. There are now several hypotheses that can coexist and all agree that the trigger for autoinflammatory processes is mediated by the HLA-B27 antigen. The first hypothesis holds that particular HLA-27 subtypes bind to peptides identified by CD8+ cells, activating autoreactive T cells [8].

The second hypothesis proposes that defective HLA-B27 folding at the endoplasmic reticulum of immune cells activates the unfolding protein response (UPR) pathway, which induces the translocation and thus activation of transcription factor NFkB to the nucleus, resulting in the production of cytokines involved in disease pathogenesis by various inflammatory cells. Innate immune system cells are involved in the beginning and progression of SpA, and monocytes have been shown to play a critical role in the pathogenesis of these disorders. Monocytes are classified into three types based on the expression of the surface antigens CD14 and CD16. The most prevalent population, classical monocytes (approximately 90%), express high levels of CD14 but lack CD16 (CD14++ CD16-).Macrophages are innate immune system cells that are found in all tissues and body compartments and act as the initial line of defence against infection. They are the primary phagocytic cells, but they also serve as antigen presenters and release cytokines that aid in immune system activation. Macrophages are also important in the preservation of tissue homeostasis and in the orchestration of chronic inflammation seen in a variety of illnesses, including SpA.

Spondyloarthritis (SpA) refers to a group of chronic inflammatory illnesses, the most common of which are ankylosing spondylitis (AS) and psoriatic arthritis (PsA). These disorders share genetic, clinical, and immunological characteristics, such as the involvement of human leukocyte antigen (HLA) class I molecule 27 (HLA-B27), peripheral, spine, and sacroiliac joint inflammation, and the existence of extra-articular symptoms (psoriasis, anterior uveitis, enthesitis and inflammatory bowel disease).

References

  1. Nichols, Bainton, Dorothy Ford, Farquhar, Marilyn G, et al. (1971) Differentiation of monocytes. Journal of Cell Biology 50: 498-515.
  2. Google Scholar, Crossref     

  3. Zini G (2021) How I investigate difficult cells at the optical microscope. Int J Lab Hematol 43: 346-353.
  4. Google Scholar, Crossref, Indexed at

  5. Monga I, Kaur K, Dhanda S (2022) Revisiting hematopoiesis: applications of the bulk and single-cell transcriptomics dissecting transcriptional heterogeneity in hematopoietic stem cells. Briefings in Functional Genomics 21: 159-176.
  6. Google Scholar, Crossref, Indexed at

  7. Ziegler-Heitbrock, HW Loems, Passlick Bernward, Flieger Dimitri (1988) The Monoclonal Antimonocyte Antibody My4 Stains B Lymphocytes and Two Distinct Monocyte Subsets in Human Peripheral Blood. Hybridoma 7: 521-527.
  8. Google Scholar, Crossref, Indexed at

  9. Passlick Bernward, Flieger Dimitri, Ziegler-Heitbrock, HW Loems (1989) Characterization of a human monocyte subpopulation coexpressing CD14 and CD16 antigens. Blood 74: 2527-2534.
  10. Google Scholar, Crossref, Indexed at

  11. Ziegler-Heitbrock, Loems (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81: 584-592.
  12. Google Scholar, Crossref, Indexed at

  13. Hofer Thomas P, Van de Loosdrecht Arjan A, Stahl-Hennig Christiane, Cassatella Marco A, Ziegler-Heitbrock Loems, et al. (2019) 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes. Frontiers in Immunology 10: 2052.
  14. Google Scholar, Crossref, Indexed at

  15. Ghattas Angie, Griffiths Helen R, Devitt Andrew, Lip Gregory YH, Shantsila Eduard, et al. (2013) Monocytes in Coronary Artery Disease and Atherosclerosis. . Am Coll Cardiol 62: 1541-1551.
  16. Google Scholar, Crossref, Indexed at

Citation: Jonsson R (2022) Significance of Monocytes & Macrophages in Spondyloarthritis. Acta Rheuma, Vol. 9 No.4: 11.